Filing Details
- Accession Number:
- 0001214659-21-002670
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-03 16:36:26
- Reporting Period:
- 2021-03-01
- Accepted Time:
- 2021-03-03 16:36:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1581280 | Twist Bioscience Corp | TWST | Biological Products, (No Disgnostic Substances) (2836) | 462058888 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1753840 | Mark Daniels | C/O Twist Bioscience Corporation 681 Gateway Blvd. South San Francisco CA 94080 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-01 | 1,166 | $26.66 | 68,092 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-03-01 | 377 | $8.82 | 68,469 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-01 | 1,543 | $140.78 | 66,926 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-03-01 | 1,166 | $0.00 | 1,166 | $26.66 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-03-01 | 377 | $0.00 | 377 | $8.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 37,344 | 2028-11-18 | No | 4 | M | Direct | |
| 2,638 | 2027-09-28 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020.
- 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Billionaire Hedge Funds
